Introduction:
Von Hippel-Lindau (VHL) disease is a genetic condition characterized by the abnormal growth of benign and malignant tumors and cysts in numerous bodily regions. Tumors typically manifest themselves throughout adolescence or early adulthood. The hemangioblastomas (slow-growing tumors of the central nervous system), kidney cysts, clear cell renal cell carcinoma, pancreatic neuroendocrine tumors, pheochromocytomas (noncancerous tumors of the adrenal glands), and endolymphatic sac tumors are also related with von Hippel-Lindau disease and are caused by a VHL gene mutation that is inherited. It is critical to detect and treat VHL disease early, which typically requires surgical removal of tumors.
What Are the Other Names of von Hippel-Lindau Disease?
The other names of this condition are:
-
Angiomatosis retinae.
-
Cerebelloretinal angiomatosis.
-
VHL syndrome.
-
Hippel-Lindau disease.
What Is von Hippel-Lindau Disease?
Von Hippel-Lindau syndrome (VHL) is a genetic abnormality linked to several organ tumors. Hemangioblastomas, brain, spinal cord, and retinal blood vessel cancers, are associated with VHL. Tumors, noncancerous or cancerous, most commonly emerge in young adults, while von Hippel-Lindau syndrome symptoms can occur at any age.
How Common Is von Hippel-Lindau Disease?
VHL is predicted to affect approximately one in every 30,000 persons. Around ten percent of patients with VHL have no family history of the disease. They have a de novo mutation, which means that the VHL gene has a new mutation that was not present in their parents.
What Causes von Hippel-Lindau Disease?
-
When the von Hippel-Lindau gene is functioning properly, it produces a protein that aids in the regulation of cell development. When a gene is mutated, it is unable to create healthy copies of the protein. Cells behave as if they are depriving themselves of oxygen. As a result, the body produces an excessively high number of blood vessels around the affected cells, causing them to rupture. Tumors and cysts may then occur in the affected areas as a result.
-
The risk of acquiring specific types of cancers and other VHL characteristics can be passed down across generations. VHL is also the name of the gene associated with VHL. Inheriting a deletion or mutation (alteration) in the VHL gene increases a person's likelihood of getting the disease. Almost everyone with VHL syndrome carries a specific VHL genetic mutation.
What Are the Signs and Symptoms of von Hippel-Lindau Disease?
1. There is no single specific symptom associated with VHL illness. This is partly due to the fact that it does not manifest itself in a single organ of the body. As previously stated, it also does not always affect people of a particular age range. Even though the disorder is inherited, the presentation of the disease can vary significantly between individuals, even when the same genetic mutation is present. Furthermore, because the form and severity of VHL lesions differ so widely from person to person, several members of the same family may suffer from only a few problems. In contrast, others may suffer from significant sickness.
2. Hemangioblastomas are the most typical manifestation of von Hippel-Lindau Disease. Hemangioblastomas are noncancerous tumors. It is possible to develop these benign tumors in the brain, spinal cord, or retina.
3. In some situations, the hemangioblastoma in the brain or spinal cord may be trapped within a cyst or fluid-filled sac. Because of the pressure exerted by the hemangioblastomas or adjacent cysts on nerve or brain tissue, patients may have symptoms such as:
- Headaches.
- Balance problems while walking, and weakening of the arms and legs.
- Blood or fluid leaks from hemangioblastomas in the eyes can cause vision to become blurred or impaired.
4. In the case of adrenal tumors, high blood pressure, panic attacks, and excessive perspiration are possible early indications.
5. Early symptoms of pancreatic cysts and tumors may include digestive issues such as bloating and disturbances in bowel and bladder function, among other things.
6. In the early stages of renal cell carcinoma, kidney tumors and cysts (clear cell renal cell carcinoma) might cause impaired kidney function, although there are usually no symptoms.
How Is Von Hippel-Lindau Disease Diagnosed?
1. The only way to determine whether or not someone has VHL is by genetic testing. When persons with VHL are screened, it is almost always discovered that they have a genetic mutation in their VHL gene.
2. Individuals should be screened for VHL based on their risk factors, but there are no universal protocols. It is essential to suspect VHL if someone exhibits any of the following symptoms:
- Hemangioblastomas of the brain, spinal cord, eye, or a combination of these conditions.
- Hemangioblastoma and ccRCC (cancer in both kidneys), pancreatic cysts, pheochromocytoma, endolymphatic sac tumor, or an epididymal cyst are all possible diagnoses for this patient.
3. Whenever a person has a family history of VHL, they are presumed to have the disease if they have any one of the symptoms listed above, including hemangioblastoma of the brain or spine, kidney cancer, pancreatic cysts, pheochromocytoma, or endolymphatic sac tumor.
4. The clinical tests done to establish a diagnosis if the person has any of the above-mentioned symptoms include:
5. Blood and urinary catecholamine metabolites.
6. MRI (magnetic resonance imaging) of the brain and spinal cord.
7. Fundoscopy - A fundoscopy or ophthalmoscopy is a test used to view the fundus or back of the eye along with structures like the retina, optic nerve head, and blood vessels.
8. Ultrasound examination or MRI (magnetic resonance imaging) of the abdomen.
How Is Von Hippel-Lindau Disease Treated?
There is no definitive, recommended universal treatment for this condition. Only a thorough examination of the complete situation of the individual, including symptoms, test findings, imaging examinations, and overall physical condition, can determine treatment options. The treatment approaches can be nonsurgical therapies or surgeries, depending on the complications and concerns.
1. Nonsurgical Treatment Considerations - Nonsurgical therapy approaches prevent complications and provide scheduled follow-up. For example, due to the danger of developing retinal hemangioblastomas, it is recommended to have an annual ophthalmologic checkup. It is possible to lessen the risk of sight loss by detecting and treating retinal lesions early.
2. Monitoring and Evaluation - For patients with only one sign of VHL disease (for example, retinal hemangioblastoma), treating the clinical finding alone is not sufficient as the patient is at risk of developing additional, potentially life-threatening complications that may not be immediately apparent. As a result, close monitoring and timely evaluation with proper diagnostic imaging are the most critical aspects of medical care for these individuals.
3. Surgical Management -The surgical management includes ophthalmic, neurological, and renal surgeries depending upon the site of tumor or cyst development.
4. Ophthalmic Surgeries - Von Hippel-Lindau (VHL) disease is typically a progressive condition, and ophthalmic therapy should begin immediately upon diagnosis of eye pathology. Surgical intervention may include the following:
- Photocoagulation with an argon laser.
- Cryotherapy.
- Drainage of fluids.
- Buckling of the sclera.
- Surgery on the vitreous.
- Diathermy with penetration and endodiathermy.
- Radiation therapy.
5. Renal Surgeries - The most common life-threatening malignancy in people with von Hippel-Lindau (VHL) syndrome is clear renal cell carcinoma. Once detected with minimal tumor involvement, partial nephrectomy (surgical removal of part of the kidney) or radiofrequency ablation (uses radiofrequency waves to destroy the tumor) are the primary therapy options for preserving renal function.
6. Total Nephrectomy - It is reserved for patients with a large amount of tumor involvement.
7. Bilateral Nephrectomy - If several primary kidney tumors exist, bilateral nephrectomy may eventually be required in some cases.
8. Kidney Dialysis or Renal Transplants - It is necessary to maintain life following these renal surgeries.
9. Neurological Surgeries - Because CNS (central nervous system) hemangioblastomas are generally benign, they can be evaluated to ensure that their size remains stable and does not cause focal neurologic symptoms. However, if these tumors induce neurologic symptoms, they must be removed through neurosurgery.
Conclusion:
Consultation with a medical geneticist and a genetic counselor is essential following a von Hippel-Lindau (VHL) illness diagnosis. Genetic counseling is crucial since VHL illness diagnosis affects at-risk family members. Psychological and psychiatric intervention may be necessary to solve the emotional burden associated with this chronic disease diagnosis.
